iBio, Inc.
iBio, Inc. (IBIO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ibio · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$5.00
+189.0% upside
Low
$5.00
Median: $5 · Last Close: $1.73
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.78 | ↑ 3.11% |
1-day model range: $1.77–$1.8. Peak: $1.8 (+3.11%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -44.5% |
| 2028 | $1 | -56.9% |
| 2029 | $1 | -61.7% |
| 2030 | $1 | -63.8% |
| 2031 | — | -64.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IBIO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-09 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-18 | Chardan Capital | Maintains | Buy→Buy |
| 2026-02-12 | Chardan Capital | Maintains | Buy→Buy |
| 2025-06-25 | Chardan Capital | Maintains | Buy→Buy |
| 2025-05-06 | Chardan Capital | Maintains | Buy→Buy |
| 2025-05-05 | Chardan Capital | Maintains | Buy→Buy |
| 2024-06-03 | Chardan Capital | Maintains | Buy→Buy |
| 2022-10-07 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2021-11-29 | JMP Securities | Maintains | Outperform→Outperform |
| 2021-01-22 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on iBio, Inc. (IBIO) stock. Of the recent 12 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover IBIO.
Analyst Recommendation Trends
IBIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 28.0% YoY
Revenue Next Year
$0M
↓ 33.3% YoY
EPS This Year
$-0.34
EPS Next Year
$-0.32
↓ 5.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast IBIO EPS of $-0.34 for the current fiscal year, based on estimates from 4 analysts. The IBIO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IBIO stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IBIO price target is $5.00 (+189.0% upside), with an analyst consensus of Buy.
The IBIO short-term stock prediction for tomorrow is $1.78 (+3.11%). The IBIO stock price prediction for 2027 estimates an average of $1. The IBIO stock prediction for 2030 projects a range of $1–$1.
iBio, Inc. trades on NASDAQ under the ticker IBIO. The IBIO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
IBIO forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month IBIO price target is $5.00, with a high forecast of $5.00 and a low of $5.00. The median price target is shown in the chart above when available. This implies +189.0% potential upside from the current price of $1.73.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.